The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Shifting Health Policy Landscape Brings Opportunities, Responsibility to Advocate for Rheumatology

Shifting Health Policy Landscape Brings Opportunities, Responsibility to Advocate for Rheumatology

October 10, 2016 • By Joan M. Von Feldt, MD, MSEd, FACR, FACP

  • Tweet
  • Email
Print-Friendly Version / Save PDF
From left: ARHP President Elizabeth A. Schlenk, PhD, RN; ACR/Foundation Treasurer Paula Marchetta, MD, MBA; ACR President Joan M. Von Feldt, MD, MSEd; ACR/Foundation Secretary David I. Daikh, MD, PhD; ACR President-Elect Sharad Lakhanpal, MBBS, MD; Foundation Vice-President Abby G. Abelson, MD; and Foundation President Eric L. Matteson, MD, visited Washington, D.C., in September, where they met with members of Congress to inform them of issues of importance to ACR members.

From left: ARHP President Elizabeth A. Schlenk, PhD, RN; ACR/Foundation Treasurer Paula Marchetta, MD, MBA; ACR President Joan M. Von Feldt, MD, MSEd; ACR/Foundation Secretary David I. Daikh, MD, PhD; ACR President-Elect Sharad Lakhanpal, MBBS, MD; Foundation Vice-President Abby G. Abelson, MD; and Foundation President Eric L. Matteson, MD, visited Washington, D.C., in September, where they met with members of Congress to inform them of issues of importance to ACR members.

Heraclitus of Ephesus (c. 500 BC) is credited with the saying, “The only constant is change.” Now, centuries later, change is meteoric, and especially in healthcare and health policy, the pace of change is relentless. Rheumatology and other specialties continue to face challenges that threaten the ability to deliver compassionate, competent care to patients. The Medicare Access and CHIP Reauthorization Act (MACRA), the Part B Drug Payment Demonstration Project, tiered reimbursement, biosimilars, prior authorization and other policy decisions may have large negative impacts on our practice. Policymakers at the national and state levels are making decisions that directly affect our treatment of patients with rheumatic disease.

You Might Also Like
  • RheumPAC Advances Policy Issues of Rheumatology Professionals
  • A New Administration Brings Updated ACR Policy Positions
  • Health Policy Outlook for 2012
Explore This Issue
October 2016
Also By This Author
  • New President Dr. Von Feldt Looks at Where ACR Is Headed in 2016

How will rheumatologists have a voice in the changes that will occur? The answer lies in our own willingness to educate and advocate. Why? Because rheumatologists and rheumatology health professionals are uniquely positioned and qualified to inform policy makers about our own and our patients’ needs, and to educate policymakers about consequences, frequently unintended, that policies may have on our ability to deliver care and our patients’ ability to get care. With this in mind, let’s take a brief look at some of the major issues facing rheumatology and rheumatology practices, and what you can do.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

MACRA

MACRA is an entirely new Medicare payment system. It was the result of repealing the flawed Sustainable Growth Rate (SGR) payment formula that called for ever-growing payment cuts to physicians. MACRA shifts reimbursement from fee-for-service to pay-for-performance and will have a greater impact on rheumatologists than the Affordable Care Act.

The MACRA initiative sunsets existing quality reporting and penalty programs and establishes a single new system, the Merit-Based Incentive Payment System (MIPS), as the default fee-for-service track that most rheumatologists will take. For those able to participate in an approved Alternative Payment Model (APM), significant bonuses will be available, as well as exemption from MIPS. Physicians who participate in the ACR’s RISE Registry will have an advantage. RISE usage is expected to generate credit in three of the four MIPS categories. In addition, physician users’ reporting is handled automatically with RISE. Most importantly, what physicians do in 2017, the first performance year, will determine penalties or bonuses coming from MACRA in 2019. The Centers for Medicare & Medicaid Services (CMS) recently announced it has heard the concerns of the ACR and other stakeholders and will give providers more flexibility with regard to MACRA requirements in 2017. Providers will be able to choose among four options within the first year and avoid penalties.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 | Single Page

Filed Under: Legislation & Advocacy, President's Perspective Tagged With: Advocacy, American College of Rheumatology, Congress, Healthcare, legislators, Medicare, patient care, policy, Rheumatic Disease, rheumatologyIssue: October 2016

You Might Also Like:
  • RheumPAC Advances Policy Issues of Rheumatology Professionals
  • A New Administration Brings Updated ACR Policy Positions
  • Health Policy Outlook for 2012
  • Why I Advocate for Rheumatology: Teaching the Basics

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)